NEW YORK, Oct. 9 (GenomeWeb News) - Drug maker Cellular Genomics will use Affymetrix's GeneChips together with its own Analog Sensitive Kinase Allele technology to develop assays for kinase drug discovery, the companies said today.
The firms also said the collaboration, which is the first of its kind for Affy's DNA chips, will help researchers determine "all the changes in cellular gene expression resulting from exquisitely specific small molecule-mediated human kinase target inhibition."
Cellular Genomics ASKA technology relies on small molecule analog inhibitors that inhibit genetically modified kinases.